NCT01331447View on ClinicalTrials.gov

Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Breast Cancer
Interventions
DRUG

exemestane

25 mg tablet

Trial Locations (1)

65802

BioKinetic Clinical Applications, Inc., Springfield

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT01331447 - Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions | Biotech Hunter | Biotech Hunter